CMC(SH:600327)2026-01-29 09:00Financial Performance - The company expects a net loss attributable to shareholders of between -235 million and -175 million CNY for the fiscal year 2025, compared to a profit of 19.87 million CNY in the same period last year[1][2][4]. - The projected net profit after deducting non-recurring gains and losses for 2025 is estimated to be between -215 million and -155 million CNY[1][4]. - The total profit for the previous year was 71.44 million CNY, with a net profit attributable to shareholders of 1.99 million CNY[2]. Revenue and Profitability Challenges - The company faced a decline in revenue and gross profit due to a downturn in consumer spending and challenges in traditional retail channels, despite efforts to enhance customer experience and marketing[3]. - The pediatric medical business saw a revenue decline but an increase in gross profit, maintaining stable operations[3]. - The company disposed of equity and debt in the loss-making Jinhua Lianji Hospital to optimize its medical business layout, impacting profits[3]. - The investment income from certain affiliated companies decreased year-on-year due to operational losses, affecting overall profitability[5]. Financial Data and Audit Status - The financial data provided is preliminary and has not been audited by registered accountants, with no significant uncertainties affecting the accuracy of the forecast identified[6][7].